2nd Annual IBD Research Symposium and 8th Annual IBD Multidisciplinary Conference

Friday, March 27, 2026 at EPNEC- Optional
Day 1: 2nd Annual IBD Research Symposium
This day highlights cutting-edge research and translational science. Topics include emerging mechanisms of IBD pathogenesis, advanced imaging and biomarker-driven monitoring, microbiome and dietary interventions, and novel therapeutic targets. Keynote presentations and research-focused sessions aim to bridge the gap between laboratory discoveries and clinical application.

Saturday, March 28, 2026 at Chase Park Plaza
Day 2: 8th Annual IBD Multidisciplinary Conference
This day emphasizes practical, evidence-based strategies for clinical management of IBD. Sessions include therapeutic sequencing, perioperative and postoperative care, management of complex cases, and integration of nutrition and lifestyle interventions. Interactive panels and case-based discussions foster collaboration among gastroenterologists, surgeons, dietitians, and allied health professionals.

The 2nd Annual IBD Research Symposium and 8th Annual IBD Multidisciplinary Conference is planned and implemented interprofessionally by physicians and nurses. The 2nd Annual IBD Research Symposium and 8th Annual IBD Multidisciplinary Conference, planned interprofessionally, targets gastroenterologists, colorectal surgeons, nurses, imaging specialists, dieticians, and researchers. This 14-hour live course features lectures, case presentations, panel discussions, and Q&A sessions addressing critical gaps in IBD management and understanding, informed by current clinical trends and research. The goal is to enhance knowledge, skills, strategies, performance, and patient care. Together, these events deliver a unique opportunity for clinicians, researchers, and multidisciplinary teams to gain actionable insights, share best practices, and collaborate to improve outcomes for patients with IBD.

1. Apply evidence based strategies for sequencing and combining therapies in UC and Crohns disease.
2. Utilize advanced imaging and biomarker tools for precision disease monitoring.
3. Identify predictors of postoperative Crohns disease recurrence and apply risk based management strategies and implement best practices for perioperative medication management and postoperative care.
4. Integrate dietary and microbiome based interventions into IBD treatment plans.
5. Address metabolic and systemic comorbidities in IBD through multidisciplinary approaches.
6. Translate emerging research on pathogenesis and novel therapeutics into clinical decision making.

1. The learning objectives emphasize applying evidence-based strategies, interpreting advanced imaging and biomarkers, and integrating research into practice. Case-based discussions and interactive panels allow participants to practice decision-making and problem-solving in realistic scenarios, reinforcing competence and performance goals.

This is a continuing medical education activity intended for healthcare providers.

*** IMPORTANT NOTE for Employees of industry (e.g., pharmaceutical & device companies): DO NOT REGISTER HERE. Please email [email protected] for pre-approval for attendance at this course. Should you register without pre-approval, your registration will be cancelled and refunded less a $25 administrative fee. 

Registration will be available until Thursday, March 26, 2026 12:00pm CT.  After this time, please register on-site.

Fees include enrollment, continuing education credits, educational materials, continental breakfast, lunch, refreshment breaks and daytime self-parking (paid registrants only).

Registration/Payment Policy: Your full payment in advance completes your registration and ensures your enrollment in this course. 

Cancellations: Registration fee less $50 administrative charge is refundable if cancellation is received in writing by emailing [email protected] by March 13, 2026. Registration fees are not transferrable.

In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis.   Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

American Medical Association (AMA)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The cancellation cut-off dates and fees are specific to each course. Refer to the cancellation policy on the individual course page. Please send cancellation requests to [email protected].

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

Continuing Medical Education at Washington University School of Medicine fully complies with the legal requirements of the Americans with Disabilities Act rules and regulations thereof. If any participant of this meeting is in need of accommodations, please do not hesitate to submit written requests, at least one month prior to seminar date.

Suggested Hotel Accommodations: 

The Chase Park Plaza Royal Sonesta St. Louis
212 N Kingshighway Blvd, St. Louis, MO 63108
Make your hotel reservations directly with the hotel.
WashU Rate: $191 + tax
Online: Chase Park Plaza
By phone: Reservations phone number is 314-633-3000

Doubletree by Hilton St. Louis Forest Park 
Adjacent to the conference center:
4550 Forest Park Ave., St. Louis, MO 63110
Make your hotel reservations directly with the hotel:
Ask for the Washington University Visitor rate.
Online at  Book your hotel Enter Code #3209101 under “special rate corporate”
By phone at 314-256-7777

Please Note: Washington University is not responsible for airline, hotel reservations or any other travel expenses. Please confirm registration acceptance prior to purchase of nonrefundable or penalty airline tickets.

Transportation:
•    Taxis from the airport are approximately $40.
•    Uber and Lyft are also available.
•    MetroLink runs from the airport to the Medical Center
     (Central West End Station) for approximately $4.00.

Washington University School of Medicine in St. Louis School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Washington University School of Medicine in St. Louis adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

This activity may be supported in part by educational grants from various commercial organizations. A complete list of commercial supporters will be available at the time of the conference. Some companies may also exhibit.

Janssen Scientific Affairs, LLC.

Merck Sharp & Dohme LLC

This activity may be supported in part by educational grants from various commercial organizations. A complete list of commercial supporters will be available at the time of the conference. Some companies may also exhibit.

Diamond

Lilly

Regeneron

Takeda

Platinum

AbbVie

Merck & Co., Inc.

Gold

Takeda

Silver

Takeda

Takeda

Bronze

This activity may be supported in part by educational grants from various commercial organizations. A complete list of commercial supporters will be available at the time of the conference. Some companies may also exhibit.

Product Theatre Sponsorship

Janssen Biotech, Inc.